Direkt zum Inhalt
Merck
Alle Fotos(2)

Dokumente

265969

Sigma-Aldrich

Lithium

rod, diam. 12.7 mm, 99.9% trace metals basis

Synonym(e):

Lithium atom, Lithium element

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(2)

About This Item

Lineare Formel:
Li
CAS-Nummer:
7439-93-2
Molekulargewicht:
6.94
EG-Nummer:
231-102-5
MDL-Nummer:
MFCD00134051
UNSPSC-Code:
12141803
PubChem Substanz-ID:
24856114
NACRES:
NA.23

Assay

99.9% trace metals basis

Form

rod

Eignung der Reaktion

reagent type: reductant

Widerstandsfähigkeit

9.446 μΩ-cm, 20°C

Durchmesser

12.7 mm

bp

1342 °C (lit.)

mp (Schmelzpunkt)

180 °C (lit.)

Dichte

0.534 g/mL at 25 °C (lit.)

Anwendung(en)

battery manufacturing

SMILES String

[Li]

InChI

1S/Li

InChIKey

WHXSMMKQMYFTQS-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

Our high-purity lithium rod with a diameter of 12.7 mm is a cylindrical piece of metal made of lithium, a highly reactive, silvery-white metal. Lithium is one of the lightest and most electropositive metals, making it highly reactive. Lithium is a good conductor of electricity and heat, has a low melting point (180 °C), and is soft and ductile.

Anwendung

Lithiummetal is widely used to fabricate anode material for rechargeable batteries dueto its low negative electrochemical potential and high theoretical specificcapacity.

Piktogramme

FlameCorrosion
GHS02,GHS05

Signalwort

Danger

H-Sätze

H260,H314

Gefahreneinstufungen

Skin Corr. 1B - Water-react 1

Zusätzliche Gefahrenhinweise

EUH014

Lagerklassenschlüssel

4.3 - Hazardous materials which set free flammable gases upon contact with water

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 7

1 of 7

Lithium ribbon, thickness × W 0.75 mm × 45 mm, 99.9% trace metals basis

Sigma-Aldrich

265993

Lithium

Lithium-6Li chunks, in mineral oil, 95 atom % 6Li

Sigma-Aldrich

340421

Lithium-6Li

Lithium foil, 25x100mm, thickness 0.6mm, as rolled, 99.9%

GF47159826

Lithium

Lithium-7Li ≥99.8 atom % 7Li, ≥99.8% (CP)

Sigma-Aldrich

601535

Lithium-7Li

Lithium foil, thickness 0.6 mm, size 25 × 300 mm, purity 99.9%

GF11597913

Lithium

Lithium-6Li-fluorid 95 atom % 6Li, 99% (CP)

Sigma-Aldrich

601411

Lithium-6Li-fluorid

Lithiumsulfid 99.98% trace metals basis

Sigma-Aldrich

213241

Lithiumsulfid

Enikö Zörgö et al.
PLoS genetics, 9(3), e1003388-e1003388 (2013-04-05)
The number of chromosome sets contained within the nucleus of eukaryotic organisms is a fundamental yet evolutionarily poorly characterized genetic variable of life. Here, we mapped the impact of ploidy on the mitotic fitness of baker's yeast and its never
Yingying Lu et al.
Nature materials, 13(10), 961-969 (2014-08-12)
Rechargeable lithium, sodium and aluminium metal-based batteries are among the most versatile platforms for high-energy, cost-effective electrochemical energy storage. Non-uniform metal deposition and dendrite formation on the negative electrode during repeated cycles of charge and discharge are major hurdles to
Rasmus W Licht
CNS neuroscience & therapeutics, 18(3), 219-226 (2011-11-11)
Still after more than 50 years, lithium is a major treatment of bipolar disorder, even though it has not been promoted by the pharmaceutical industry over the last decades. In recent years the evidence base on lithium for bipolar disorder
Mustafa Khasraw et al.
BMC medicine, 10, 131-131 (2012-11-06)
Neurocognitive impairment is being increasingly recognized as an important issue in patients with cancer who develop cognitive difficulties either as part of direct or indirect involvement of the nervous system or as a consequence of either chemotherapy-related or radiotherapy-related complications.
Annemiek Dols et al.
International clinical psychopharmacology, 28(6), 287-296 (2013-07-23)
Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.